04/21/2003
Federal Register Notice: FDA is making available a draft guidance for industry entitled Multiplex Tests for Heritable DNA Markers,...04/21/2003
Federal Register Notice: FDA’s collection of information entitled “Notice of Participation” has been approved by...04/21/2003
Federal Register Notice: FDA solicits comments on the collection of information contained in a guidance entitled Guidance for Indu...04/21/2003
Federal Register Notice: FDA has determined the regulatory review period for Alliance Pharmaceutical Corp.’s Imagent (perflu...04/21/2003
Federal Register Notice FDA has determined the regulatory review period for Zevalin (CD20 Monoclonal Antibody) is 3,363 days for t...04/21/2003
Federal Register Notice: FDA’s collection of information entitled “Medical Device Reporting: Manufacturer Reporting, I...04/21/2003
Federal Register Notice: FDA has determined the regulatory review period for Novartis’ Exelon (rivastigmine tartrate) is 3,4...